Alliancebernstein L.P. Coherus Bio Sciences, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 188,410 shares of CHRS stock, worth $207,251. This represents 0.0% of its overall portfolio holdings.

Number of Shares

188,410

Previous 188,410 -0.0%

Holding current value

$207,251

Previous $325,000 40.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.58 - $2.51 $66,217 - $105,194	41,910 Added 28.61%	188,410 $325,000
Q1 2024 May 14, 2024	SELL	$2.02 - $3.14 $19,190 - $29,830	-9,500 Reduced 6.09%	146,500 $350,000
Q3 2023 Nov 14, 2023	SELL	$3.74 - $5.45 $114,144 - $166,334	-30,520 Reduced 16.36%	156,000 $583,000
Q2 2023 Aug 15, 2023	SELL	$3.79 - $8.3 $22.6 Million - $49.4 Million	-5,950,405 Reduced 96.96%	186,520 $796,000
Q1 2023 May 15, 2023	SELL	$5.89 - $10.52 $474,928 - $848,259	-80,633 Reduced 1.3%	6,136,925 $42 Million
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $629,865 - $1.11 Million	110,697 Added 1.81%	6,217,558 $49.2 Million
Q3 2022 Nov 15, 2022	BUY	$7.17 - $13.87 $3.09 Million - $5.98 Million	431,412 Added 7.6%	6,106,861 $58.7 Million
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $809,705 - $1.83 Million	-138,175 Reduced 2.38%	5,675,449 $41.1 Million
Q1 2022 May 13, 2022	BUY	$10.92 - $16.41 $1.16 Million - $1.74 Million	105,916 Added 1.86%	5,813,624 $75.1 Million
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $17.7 Million - $21.2 Million	1,117,972 Added 24.36%	5,707,708 $91.1 Million
Q3 2021 Nov 10, 2021	BUY	$12.68 - $17.79 $1.08 Million - $1.52 Million	85,462 Added 1.9%	4,589,736 $73.8 Million
Q2 2021 Jul 30, 2021	BUY	$12.95 - $15.41 $4 Million - $4.76 Million	308,905 Added 7.36%	4,504,274 $62.3 Million
Q1 2021 May 06, 2021	SELL	$14.42 - $21.39 $7.34 Million - $10.9 Million	-508,831 Reduced 10.82%	4,195,369 $61.3 Million
Q4 2020 Feb 08, 2021	BUY	$16.56 - $18.94 $3.2 Million - $3.65 Million	192,961 Added 4.28%	4,704,200 $81.8 Million
Q3 2020 Nov 12, 2020	BUY	$17.41 - $19.89 $6.89 Million - $7.87 Million	395,787 Added 9.62%	4,511,239 $82.7 Million
Q2 2020 Aug 13, 2020	BUY	$14.43 - $19.16 $12.8 Million - $17 Million	889,128 Added 27.56%	4,115,452 $73.5 Million
Q1 2020 May 14, 2020	BUY	$11.67 - $22.53 $12.2 Million - $23.6 Million	1,048,294 Added 48.13%	3,226,324 $52.3 Million
Q4 2019 Feb 18, 2020	BUY	$16.33 - $21.37 $26.5 Million - $34.7 Million	1,623,851 Added 293.02%	2,178,030 $39.2 Million
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $7.55 Million - $10.8 Million	463,479 Added 511.0%	554,179 $11.2 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $255,450 - $430,950	19,500 Added 27.39%	90,700 $2 Million
Q3 2018 Nov 08, 2018	BUY	$14.45 - $20.25 $31,790 - $44,550	2,200 Added 3.19%	71,200 $1.18 Million
Q2 2018 Aug 13, 2018	BUY	$10.25 - $17.45 $351,370 - $598,186	34,280 Added 98.73%	69,000 $966,000
Q1 2018 May 14, 2018	BUY	$9.1 - $13.7 $54,600 - $82,200	6,000 Added 20.89%	34,720 $384,000
Q3 2017 Nov 13, 2017	BUY	$11.1 - $14.5 $318,792 - $416,440	28,720	28,720 $383,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $85.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Coherus Bio Sciences, Inc. Transaction History